Carbamylated Erythropoietin (CEPO)

carbamylated erythropoietin · H. Lundbeck A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Carbamylated Erythropoietin (CEPO), covering 2011-04-20 to 2011-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetic Study of Carbamylated Erythropoietin (CEPO) to Treat Patients With Acute Ischemic Stroke [Phase 1]

See pricing